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Abstract
Despite the current pandemic season, reports on pathologic features of coronavirus disease 19 (Covid-19) are exceedingly rare at
the present time. Here we describe the pathologic features of early lung involvement by Covid-19 in a surgical sample resected
for carcinoma from a patient who developed SARS-CoV-2 infection soon after surgery. The main histologic findings observed
were pneumocyte damage, alveolar hemorrhages with clustering of macrophages, prominent and diffuse neutrophilic margin-
ation within septal vessels, and interstitial inflammatory infiltrates, mainly represented by CD8+ T lymphocytes. These features
are similar to those previously described in SARS-CoV-2 infection. Subtle histologic changes suggestive pulmonary involvement
by Covid-19may be accidentally encountered in routine pathology practice, especially when extensive sampling is performed for
histology. These findings should be carefully interpreted in light of the clinical context of the patient and could prompt a
pharyngeal swab PCR test to rule out the possibility of SARS-CoV-2 infection in asymptomatic patients.
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Introduction
Coronavirus disease 19 (Covid-19) is a global pandemic
caused by the severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2). According to the WHO
Covid-19 situation report of March 29, Italy is the most
affected European country, with 92.472 total cases and
10.023 deaths. The virus is transmitted mainly by inha-
lation of respiratory droplets from both symptomatic and
asymptomatic patients. Fever, fatigue, and dry cough are
the most common symptoms at clinical presentation.
Approximately 13–20% of infected individuals develop
severe respiratory symptoms with radiological findings
of interstitial involvement, requiring assisted oxygena-
tion [1–3]. A low number of routine autopsies is per-
formed due to the high infectivity of the disease; ac-
cordingly, there are only a few reports in medical liter-
ature describing the histopathologic findings of SARS-
CoV-2 infection [4, 5]. More in-depth investigations on-
ly come from SARS-Coronavirus outbreaks in the past
[6].
Here we describe the histologic features of early lung in-
volvement by Covid-19 in a surgical sample resected for car-
cinoma from a patient who later developed SARS-CoV-2
infection.
Case report
A 61-year-old male smoker was admitted to our hospital
for surgical treatment of a lung adenocarcinoma, diag-
nosed on biopsy. His clinical history was positive for a
MALT lymphoma diagnosed 6 months before, with
complete remission after therapy. According to pre-
operatory imaging, obtained 3 weeks before surgery,
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the lesion was localized in the right inferior lobe, mea-
sured 2 cm and showed a solid appearance. There were
no ground glass opacities. At admission, the patient was
in good general condition, afebrile. A thoracoscopic lo-
bectomy with lymph node dissection (stations 2, 4, 7, 8,
9, and 10) was performed, without intraoperative com-
plications. After surgery, the patient developed progres-
sive lymphopenia (with values ranging between 920 and
340 lymphocytes/μL from the first to the fifth post-
operative day) and, on the scheduled date for discharge,
had an episode of fever (38 °C) in the absence of re-
spiratory symptoms. Thus, his antibiotic therapy was
changed, with no improvement. A pharyngeal swab
PCR test was performed, which confirmed the suspicion
of SARS-CoV-2 infection. The patient was immediately
transferred to the isolation ward where he developed
cough, dyspnea, fatigue, and high fever (38–39 °C).
SpO2 was stable between 96 and 98%. Both white
blood cells (2570/μL) and lymphocytes counts were
low (280/μL). A chest CT scan showed post-resection
changes and bilateral, peripheral, and ill-defined ground-
glass opacities, mainly involving the lower lobe, consis-
tent with Covid-19 pneumonia (Fig. 1a).
Since oxygen saturation had dropped to 35%, he re-
ceived supplemental oxygen through a CPAP mask. On
a second CT scan, performed 1 week later, the ground-
glass opacities were enlarged, with areas of consolidation
(Fig. 1b). He received a therapy based on antibiotics
(meropenem and bactrim), antiviral drugs (acyclovir and
darunavir), and on two recently approved experimental
drugs for SARS-CoV-2 infection: tocilizumab (commonly
used for the therapy of rheumatoid arthritis) and chloro-
quine hydrate (a common antimalarial drug), with an im-
provement of his conditions and clinical remission in the
following weeks.
Histologic examination of the formalin-fixed specimen
confirmed the diagnosis of lung adenocarcinoma, with a pre-
dominant acinar pattern. The lung parenchyma surrounding
the neoplasia showed diffuse hemorrhages and clusters of al-
veolar macrophages, with occasional multinucleated cells
(Fig. 2a). At higher magnification, there was evidence of both
diffuse pneumocyte loss and reactive hyperplasia, with focal
pneumocytes showing nuclear inclusions (Fig. 3a, b). There
were scanty fibrin depositions on the alveolar surfaces, in the
absence of hyaline membranes (Fig. 2c). The interstitium
showed edema and a mild inflammatory infiltrate, mainly
composed of cytotoxic (CD8+) T lymphocytes (Fig. 3c–f).
Interestingly, there were diffuse aspects of neutrophil margin-
ation within small arterioles (Fig. 3d). Occasional fibrous
plugs were also observed (Fig. 3c). Interstitial changes were
more marked in the subpleural area, where mild fibrous thick-
ening of alveolar septa was also observed (Fig. 2b).
Finally, areas of smoking-related interstitial fibrosis, con-
sistent with the patient’s habits, were also present.
Discussion
In this report, we provide a detailed analysis of the early
histologic changes of pulmonary SARS-CoV-2 infection.
Fig. 1 High-resolution CT scans performed one (a) and two (b) weeks after surgery, respectively show ground glass bilateral opacities, enlarging with
time, with the additional finding of areas of consolidation
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Fig. 2 a (× 20) Alveolar hemorrhages and clusters of macrophages with occasional giant cells (arrow). b (× 10) The alveolar septa show mild fibrous
thickening limited to the subpleural area. c (× 10) Fibrin deposits admixed with red blood cells and inflammatory infiltrates (H&E)
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Similar to the two previously published cases from China
[5], the virus-related alterations were an incidental finding
in a surgical sample sent to the Pathology Department for
routine diagnostic work-up of lung cancer, before the on-
set of clear clinical signs and symptoms of Covid-19. As
early radiological changes have been demonstrated in the
asymptomatic phase of infection [7], we emphasize the
importance of recognizing early subtle histological chang-
es in lung surgical specimens.
The main histologic findings herein described are
pneumocyte damage, alveolar hemorrhage and clustering of
macrophages, and interstitial inflammatory infiltrates, with
prominent and diffuse neutrophilic margination within septal
vessels. These features are similar to those described in
SARS-CoV-2 infection and are consistent with the previously
postulated mechanisms underlying pulmonary damage in
SARS [8, 9]: the interaction between the virus and both
pneumocytes and alveolar macrophages triggers a cascade of
immunological events, with the production of cytokines and
Fig. 3 a (× 40) Pneumocyte desquamation (arrow) and reactive hyper-
plasia with focal nuclear inclusion (asterisk). Abundant hemosiderin pig-
ment is present within alveolar macrophages. b (× 40) Diffuse
pneumocyte loss (arrows) and alveolar septal thickening. c (× 40)
Inflammatory infiltrates and fibrous plugs as those observed in organizing
pneumonia (arrow). d (× 40) Neutrophilic vascular margination and ede-
ma of the alveolar wall. e Diffuse interstitial lymphocyte infiltrate and
intra-alveolar macrophages (H&E). f (× 20) CD8 immunostaining shows
a prevalence of cytotoxic T lymphocytes (immunoperoxidase stain)
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chemokines and expression of adhesion molecules by
pneumocytes. This in turn drives an inflammatory response
with prominent macrophages, neutrophils, and T CD8+ lym-
phocytes, which is responsible for the diffuse alveolar damage
observed in the more severe and advanced stage of the disease.
Indeed, diffuse alveolar damage (DAD) has been reported as a
common autopsy finding in SARS-CoV [6, 10–13]. A recent
autopsy report highlights the finding of diffuse alveolar dam-
age as the major lung feature also in severe SARS-CoV-2
infection [4]. However, the absence of DAD does not rule
out the possibility of Covid-19 pneumonia, in the early stage
of disease [12].
Interestingly, in our case, histologic findings were more
marked and diffused in the subpleural region. This is consis-
tent with the higher frequency of peripheral and subpleural
involvement on high-resolution CT scan recently reported in
a cohort of 81 patients with Covid-19 pneumonia [3].
Covid-19 has been shown to strike elderly patients
with higher frequency and worse clinical outcome espe-
cially in the presence of comorbidities (e.g., chronic
obstructive pulmonary disease and malignancy) [14,
15]. A male predilection has also been recognized
[14]. We speculate that the rapid disease evolution ob-
served in our patient could be due to pre-existing lung
alterations induced by smoking, although there are no
evidences supporting a correlation between smoking and
severity of the disease [16].
In conclusion, during the current pandemic season, subtle
pulmonary histologic changes suggestive of SARS-CoV-2 in-
fection may be accidentally encountered in routine pathology
practice, especially if extensive sampling is performed for
histology.
These findings should be carefully interpreted in light of
the clinical context of the patient and could prompt a pharyn-
geal swab PCR test to rule out the possibility of SARS-CoV-2
infection in asymptomatic patients.
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